124 related articles for article (PubMed ID: 7552513)
1. Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.
Ferre F; Moss RB; Daigle A; Richieri SP; Jensen F; Carlo DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S51-6. PubMed ID: 7552513
[TBL] [Abstract][Full Text] [Related]
2. Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells.
Lillo FB; Grasso MA; Lodini S; Bellotti MG; Colucci G
J Virol Methods; 2004 Sep; 120(2):201-5. PubMed ID: 15288963
[TBL] [Abstract][Full Text] [Related]
3. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
[TBL] [Abstract][Full Text] [Related]
4. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
Vitone F; Gibellini D; Schiavone P; Re MC
J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
[TBL] [Abstract][Full Text] [Related]
5. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
6. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
Pasternak AO; Jurriaans S; Bakker M; Berkhout B; Lukashov VV
AIDS; 2010 Jul; 24(11):1641-9. PubMed ID: 20543660
[TBL] [Abstract][Full Text] [Related]
7. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
Rouzioux C; Hubert JB; Burgard M; Deveau C; Goujard C; Bary M; Séréni D; Viard JP; Delfraissy JF; Meyer L;
J Infect Dis; 2005 Jul; 192(1):46-55. PubMed ID: 15942893
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
9. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of HIV-1 DNA after therapy discontinuation.
Re MC; Vitone F; Sighinolfi L; Schiavone P; Ghinelli F; Gibellini D
BMC Infect Dis; 2005 Sep; 5():69. PubMed ID: 16156892
[TBL] [Abstract][Full Text] [Related]
11. Potential applications of proviral load measurement in clinical retrovirology.
Conway B; Montpetit M; Raboud J; Salas T; Dufour D; Montaner JS; O'Shaughnessy MV
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S45-50. PubMed ID: 7552512
[TBL] [Abstract][Full Text] [Related]
12. Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies.
Lafeuillade A; Poggi C; Hittinger G; Counillon E; Emilie D
J Infect Dis; 2003 Nov; 188(10):1426-32. PubMed ID: 14624367
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
[TBL] [Abstract][Full Text] [Related]
15. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers.
Montano M; Russell M; Gilbert P; Thior I; Lockman S; Shapiro R; Chang SY; Lee TH; Essex M
J Infect Dis; 2003 Aug; 188(3):406-13. PubMed ID: 12870122
[TBL] [Abstract][Full Text] [Related]
16. Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens.
Sarmati L; Parisi SG; Nicastri E; d'Ettorre G; Andreoni C; Dori L; Gatti F; Montano M; Buonomini AR; Boldrin C; Palù G; Vullo V; Andreoni M
J Med Virol; 2007 Jul; 79(7):880-6. PubMed ID: 17516532
[TBL] [Abstract][Full Text] [Related]
17. Viral phenotype and genotype as markers in clinical trials.
Katzenstein DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S25-34. PubMed ID: 7552510
[TBL] [Abstract][Full Text] [Related]
18. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 load quantitation: a 17-year perspective.
Holodniy M
J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
